Publications

mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease.

Zekavat SM, Viana-Huete V, Matesanz N, et al. mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease. Nature cardiovascular research. 2023;2:144-158. doi:10.1038/s44161-022-00206-6

SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancers.

Shi L, Shen W, Davis MI, et al. SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancers. Nature cancer. 2023;4(3):365-381. doi:10.1038/s43018-023-00523-0

Clinical importance of the lncRNA NEAT1 in cancer patients treated with immune checkpoint inhibitors.

Toker J, Iorgulescu B, Ling AL, et al. Clinical importance of the lncRNA NEAT1 in cancer patients treated with immune checkpoint inhibitors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2023. doi:10.1158/1078-0432.CCR-22-3714

An efficient landmark model for prediction of suicide attempts in multiple clinical settings.

Sheu YH, Sun J, Lee H, et al. An efficient landmark model for prediction of suicide attempts in multiple clinical settings. Psychiatry research. 2023;323:115175. doi:10.1016/j.psychres.2023.115175

High rifampicin peak plasma concentrations accelerate the slow phase of bacterial decline in tuberculosis patients: Evidence for heteroresistance.

Martinecz A, Boeree MJ, Diacon AH, et al. High rifampicin peak plasma concentrations accelerate the slow phase of bacterial decline in tuberculosis patients: Evidence for heteroresistance. PLoS computational biology. 2023;19(4):e1011000. doi:10.1371/journal.pcbi.1011000

Impact of an Expanded Definition of Family History on Outcomes of Active Surveillance for Prostate Cancer.

Schneider AC, Chandrasekar T, Bowler N, et al. Impact of an Expanded Definition of Family History on Outcomes of Active Surveillance for Prostate Cancer. The Journal of urology. 2023;209(6):1112-1119. doi:10.1097/JU.0000000000003396

Engineered Escherichia coli for the in situ secretion of therapeutic nanobodies in the gut.

Lynch JP, González-Prieto C, Reeves AZ, et al. Engineered Escherichia coli for the in situ secretion of therapeutic nanobodies in the gut. Cell host & microbe. 2023;31(4):634-649.e8. doi:10.1016/j.chom.2023.03.007

The origins and functional effects of postzygotic mutations throughout the human life span.

Rockweiler NB, Ramu A, Nagirnaja L, et al. The origins and functional effects of postzygotic mutations throughout the human life span. Science (New York, N.Y.). 2023;380(6641):eabn7113. doi:10.1126/science.abn7113

Multi-ancestry genome-wide association analyses improve resolution of genes and pathways influencing lung function and chronic obstructive pulmonary disease risk.

Shrine N, Izquierdo AG, Chen J, et al. Multi-ancestry genome-wide association analyses improve resolution of genes and pathways influencing lung function and chronic obstructive pulmonary disease risk. Nature genetics. 2023;55(3):410-422. doi:10.1038/s41588-023-01314-0

Produces a pH-Responsive Lipid Immunogen.

Kwon J, Bae M, Szamosvári D, et al. Produces a pH-Responsive Lipid Immunogen. Journal of the American Chemical Society. 2023;145(13):7071-7074. doi:10.1021/jacs.3c00250

ӳ����ý

Publications

ӳ��ý